SABCS

Negative Findings Show Herceptin Fails to Benefit Breast Cancer Subgroup

December 7th 2017, 12:52am

The combination use of Herceptin plus standard adjuvant chemotherapy does not improve outcomes in women with HER2-low breast cancer.

Alternative Chemotherapy Dosing Strategies Improve Breast Cancer Outcomes

December 6th 2017, 11:52pm

Article

For women with early-stage breast cancer who are receiving chemotherapy, shortening the time between treatment cycles or administering the agents sequentially may reduce disease recurrence and mortality compared with standard chemotherapy regimens.

Latest News

How Breast Cancer Treatment Can Impact Menopause and Fertility

FDA Grants Exousia Pro Orphan Drug Designation in Glioma

Sharing Insights Into a Multiple Myeloma Journey

What to Know About the FDA Approval of Blenrep for Multiple Myeloma

View More Latest News